Skip to Content

Paromomycin use while Breastfeeding

Drugs containing Paromomycin: Humatin, Paromycin

Medically reviewed by Drugs.com. Last updated on Aug 13, 2021.

Paromomycin Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the clinical use of paromomycin during breastfeeding. Because paromomycin is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Davidson RN, den Boer M, Ritmeijer K. Paromomycin. Trans R Soc Trop Med Hyg. 2009;103:653–60. [PubMed: 18947845]

Substance Identification

Substance Name

Paromomycin

CAS Registry Number

7542-37-2

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Amebicides

Anti-Bacterial Agents

Aminoglycosides

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.